CB Insights – AI in Clinical Development: Scouting Reports

The main theme of the report is the use of artificial intelligence (AI) in clinical development.

Key findings include: AI reduces clinical trial costs by compressing timelines. Nearly 80% of analyzed companies use AI for automation to eliminate inefficiencies that drive up costs. Trial design is no longer guesswork—it is guided in real-time. More than half of the companies apply AI for patient recruitment and protocol optimization. Decentralized trials and real-world evidence represent rapidly evolving applications.